Brief: Indian Pharma Firm Solara says Facility Completes U.S. FDA Inspection with Zero 483s
08/07/2019 06:21
July 8 (Reuters) - Solara Active Pharma Sciences Ltd
SOLA.NS :
* SAYS CUDDALORE FACILITY IN SOUTH INDIA COMPLETES U.S. FDA
INSPECTION WITH ZERO FDA FORM 483S
Source text for Eikon: ID:nBSE1kQ5MQ
Further company coverage: SOLA.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Solara Active Pharma Sciences
See all newsIndia's Solara Active Pharma Sciences rises after quarterly profit
Brief: Solara Active Pharma Sciences Says Sept-Quarter Consol Net Profit 284.6 Million Rupees
Brief: Solara Active Pharma Sciences Says Tax Demand Of 1.62 Billion Rupees Reduced To Nil After Rectification
Brief: Solara Active Pharma Sciences June-Quarter Consol Net Profit 163.1 Million Rupees
Brief: Solara Active Pharma Sciences March-Quarter Consol Net Profit 96 Million Rupees